| Item Type | Name |
|
Concept
|
Immunoglobulin A
|
|
Concept
|
Receptor, Notch1
|
|
Concept
|
Odds Ratio
|
|
Concept
|
Autoantibodies
|
|
Concept
|
Costimulatory and Inhibitory T-Cell Receptors
|
|
Concept
|
Infarction
|
|
Concept
|
Permeability
|
|
Concept
|
Botulinum Toxins, Type A
|
|
Concept
|
Homologous Recombination
|
|
Concept
|
Epithelial Cells
|
|
Concept
|
Age Factors
|
|
Concept
|
Ki-67 Antigen
|
|
Concept
|
Prognosis
|
|
Concept
|
Databases, Factual
|
|
Concept
|
Secondary Prevention
|
|
Concept
|
Informed Consent
|
|
Concept
|
DNA-Binding Proteins
|
|
Concept
|
Botulinum Toxins
|
|
Concept
|
Xeroderma Pigmentosum Group A Protein
|
|
Concept
|
Pancreas
|
|
Concept
|
NF-kappa B
|
|
Concept
|
Data Interpretation, Statistical
|
|
Concept
|
Morphine
|
|
Concept
|
Cell Lineage
|
|
Concept
|
Pilot Projects
|
|
Concept
|
Jejunum
|
|
Concept
|
BRCA1 Protein
|
|
Concept
|
Sinusitis
|
|
Concept
|
Ubiquitin-Protein Ligases
|
|
Concept
|
Colorectal Neoplasms, Hereditary Nonpolyposis
|
|
Concept
|
Rhinitis
|
|
Concept
|
Tumor Suppressor Protein p53
|
|
Concept
|
Insulin Receptor Substrate Proteins
|
|
Concept
|
Age of Onset
|
|
Concept
|
Cross-Over Studies
|
|
Concept
|
Keratin-20
|
|
Concept
|
Medicine, Arabic
|
|
Concept
|
Receptors, G-Protein-Coupled
|
|
Concept
|
Genetic Testing
|
|
Concept
|
Feasibility Studies
|
|
Concept
|
Random Allocation
|
|
Concept
|
Patient Acceptance of Health Care
|
|
Concept
|
Opioid-Related Disorders
|
|
Concept
|
Macrophages
|
|
Concept
|
Serpins
|
|
Concept
|
Interleukin-17
|
|
Concept
|
Cluster Analysis
|
|
Concept
|
Period Circadian Proteins
|
|
Concept
|
Sex Factors
|
|
Concept
|
Eye Proteins
|
|
Concept
|
Ganciclovir
|
|
Concept
|
Population Surveillance
|
|
Concept
|
Nerve Growth Factors
|
|
Concept
|
Luciferases
|
|
Concept
|
Data Mining
|
|
Concept
|
Mass Screening
|
|
Concept
|
Quality Indicators, Health Care
|
|
Concept
|
Aspartate Aminotransferases
|
|
Concept
|
Cell Transformation, Neoplastic
|
|
Concept
|
Ubiquitination
|
|
Concept
|
Myocardial Reperfusion
|
|
Concept
|
Practice Guidelines as Topic
|
|
Concept
|
Transcriptome
|
|
Concept
|
Cadherins
|
|
Concept
|
Treatment Outcome
|
|
Concept
|
Sensitivity and Specificity
|
|
Concept
|
Registries
|
|
Concept
|
Polymorphism, Single Nucleotide
|
|
Concept
|
Cohort Studies
|
|
Concept
|
Cell-Derived Microparticles
|
|
Concept
|
Protein Splicing
|
|
Concept
|
Mercaptopurine
|
|
Concept
|
Analgesics, Opioid
|
|
Concept
|
Pancreatic Neoplasms
|
|
Concept
|
Radiography
|
|
Concept
|
Carcinoma, Squamous Cell
|
|
Concept
|
Rhinitis, Allergic
|
|
Concept
|
Mice, SCID
|
|
Concept
|
Prevalence
|
|
Concept
|
Freezing
|
|
Concept
|
Case-Control Studies
|
|
Concept
|
Pennsylvania
|
|
Concept
|
Olfaction Disorders
|
|
Concept
|
Predictive Value of Tests
|
|
Concept
|
Reproducibility of Results
|
|
Concept
|
Prospective Studies
|
|
Concept
|
Deglutition Disorders
|
|
Concept
|
Leptin
|
|
Concept
|
Cross-Sectional Studies
|
|
Concept
|
Proto-Oncogene Proteins p21(ras)
|
|
Concept
|
Inflammatory Bowel Diseases
|
|
Concept
|
Carcinoma, Pancreatic Ductal
|
|
Concept
|
Azathioprine
|
|
Concept
|
Surveys and Questionnaires
|
|
Concept
|
Cell Line
|
|
Concept
|
RNA, Ribosomal, 16S
|
|
Concept
|
Pneumonia, Viral
|
|
Concept
|
Intestinal Absorption
|
|
Concept
|
Biopsy
|
|
Concept
|
Observer Variation
|
|
Concept
|
Obesity
|
|
Concept
|
Reagent Kits, Diagnostic
|
|
Concept
|
Cell Differentiation
|
|
Concept
|
Cyclooxygenase 2
|
|
Concept
|
Occludin
|
|
Concept
|
Insulin Resistance
|
|
Concept
|
Tumor Necrosis Factor-alpha
|
|
Concept
|
Coronavirus Infections
|
|
Concept
|
Prebiotics
|
|
Concept
|
Angiography
|
|
Concept
|
Neuromuscular Agents
|
|
Concept
|
Carcinogenesis
|
|
Concept
|
Long Interspersed Nucleotide Elements
|
|
Concept
|
Risk Assessment
|
|
Concept
|
Mast Cells
|
|
Concept
|
Risk Factors
|
|
Concept
|
Promoter Regions, Genetic
|
|
Concept
|
Proto-Oncogene Proteins
|
|
Concept
|
ErbB Receptors
|
|
Concept
|
Follow-Up Studies
|
|
Concept
|
Immunohistochemistry
|
|
Concept
|
Comorbidity
|
|
Concept
|
Cell Line, Tumor
|
|
Concept
|
Tumor Suppressor Proteins
|
|
Concept
|
Receptors, Cytoplasmic and Nuclear
|
|
Concept
|
Thioguanine
|
|
Concept
|
Diabetes Mellitus, Type 2
|
|
Concept
|
Genes, ras
|
|
Concept
|
Codon
|
|
Concept
|
Lectins, C-Type
|
|
Concept
|
Retrospective Studies
|
|
Concept
|
Cell Polarity
|
|
Concept
|
Receptors, Opioid, mu
|
|
Concept
|
Models, Statistical
|
|
Concept
|
HT29 Cells
|
|
Concept
|
Immunoglobulin M
|
|
Concept
|
Stem Cells
|
|
Concept
|
Caco-2 Cells
|
|
Concept
|
Alanine Transaminase
|
|
Concept
|
Chromogranin A
|
|
Concept
|
Food Supply
|
|
Concept
|
Alcoholism
|
|
Concept
|
Gastrointestinal Hemorrhage
|
|
Concept
|
Arachidonate 5-Lipoxygenase
|
|
Concept
|
DNA Mutational Analysis
|
|
Concept
|
Suprachiasmatic Nucleus
|
|
Concept
|
Immunoglobulin G
|
|
Concept
|
Severity of Illness Index
|
|
Concept
|
Cell Proliferation
|
|
Academic Article
|
P53 mutations in colorectal cancer from northern Iran: Relationships with site of tumor origin, microsatellite instability and K-ras mutations.
|
|
Academic Article
|
Inflammation in sporadic colorectal cancer.
|
|
Academic Article
|
Applying a natural language processing tool to electronic health records to assess performance on colonoscopy quality measures.
|
|
Academic Article
|
The insulin receptor substrate 1 (IRS1) in intestinal epithelial differentiation and in colorectal cancer.
|
|
Academic Article
|
Epidemiological transition of colorectal cancer in developing countries: environmental factors, molecular pathways, and opportunities for prevention.
|
|
Academic Article
|
Expression of an Oncogenic BARD1 Splice Variant Impairs Homologous Recombination and Predicts Response to PARP-1 Inhibitor Therapy in Colon Cancer.
|
|
Academic Article
|
Light/Dark Shifting Promotes Alcohol-Induced Colon Carcinogenesis: Possible Role of Intestinal Inflammatory Milieu and Microbiota.
|
|
Academic Article
|
Erratum to: LINE-1 is preferentially hypomethylated within adenomatous polyps in the presence of synchronous colorectal cancer.
|
|
Academic Article
|
Alcohol Feeding in Mice Promotes Colonic Hyperpermeability and Changes in Colonic Organoid Stem Cell Fate.
|
|
Academic Article
|
Feasibility of Colon Cancer Screening by Fecal Immunochemical Test in Iran.
|
|
Academic Article
|
KRAS mutation and epithelial-macrophage interplay in pancreatic neoplastic transformation.
|
|
Academic Article
|
Nutraceuticals in colorectal cancer: A mechanistic approach.
|
|
Academic Article
|
Abnormal Eating Patterns Cause Circadian Disruption and Promote Alcohol-Associated Colon Carcinogenesis.
|
|
Academic Article
|
Circadian rhythms and the gut microbiota: from the metabolic syndrome to cancer.
|
|
Academic Article
|
Novel role of the Mu-opioid receptor in pancreatic cancer: potential link between opioid use and cancer progression.
|
|
Academic Article
|
Gut-on-chip for ecological and causal human gut microbiome research.
|
|
Academic Article
|
Correction to: Novel role of the Mu-opioid receptor in pancreatic cancer: potential link between opioid use and cancer progression.
|
|
Academic Article
|
Presence of CrkI-containing microvesicles in squamous cell carcinomas could have ramifications on tumor biology and cancer therapeutics.
|
|
Academic Article
|
Reorganization of pancreas circadian transcriptome with aging.
|
|
Academic Article
|
Human cytomegalovirus infection enhances 5-lipoxygenase and cycloxygenase-2 expression in colorectal cancer.
|
|
Concept
|
Poly(ADP-ribose) Polymerase Inhibitors
|
|
Concept
|
RAW 264.7 Cells
|
|
Concept
|
Celecoxib
|
|
Concept
|
Transcription Factor HES-1
|
|
Concept
|
Syk Kinase
|
|
Concept
|
Proof of Concept Study
|